Skip to main navigation
Skip to search
Skip to main content
Houston Methodist Scholars Home
Home
Experts
Research units
Cores
Projects
Research output
Prizes
Search by expertise, name or affiliation
Pharmacotherapy versus T lymphocytes for CMV
Helen E. Heslop
Academic Institute
Houston Methodist
Research output
:
Contribution to journal
›
Comment/debate
›
peer-review
2
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pharmacotherapy versus T lymphocytes for CMV'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Allogeneic Hematopoietic Stem Cell Transplant Recipients
50%
Cytomegalovirus
100%
Cytotoxic T Cells
100%
Pharmacotherapy
100%
Phase II Study
50%
T Cells
100%
Medicine and Dentistry
Cytomegalovirus
100%
Cytotoxic T-Cell
100%
Drug Therapy
100%
Hematopoietic Stem Cell Transplantation
50%
T Lymphocyte
100%